Efficacy and Safety of Lovastatin Therapy in Adolescent Girls With Heterozygous Familial Hypercholesterolemia
Authors:
- 1 September 2005
- journal article
- research article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 116 (3) , 682-688
Abstract
Objective. The present study was designed to evaluate the lipid-altering efficacy, safety, and tolerability of lovastatin treatment in adolescent girls with heterozygous familial hypercholesterolemia.Keywords
This publication has 33 references indexed in Scilit:
- Efficacy and Safety of Statin Therapy in Children With Familial HypercholesterolemiaCirculation, 2002
- Efficacy and Safety of Ezetimibe Coadministered With Atorvastatin or Simvastatin in Patients With Homozygous Familial HypercholesterolemiaCirculation, 2002
- Associations of Coronary Heart Disease Risk Factors With the Intermediate Lesion of Atherosclerosis in YouthArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young AdultsNew England Journal of Medicine, 1998
- Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemiaThe Journal of Pediatrics, 1996
- Use of cholestyramine in the treatment of children with familial combined hyperlipidemiaThe Journal of Pediatrics, 1993
- Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimensJAMA, 1990
- Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia. A multicenter study. The Lovastatin Study Group II1986
- Familial Hypercholesterolemia (One Form of Familial Type II Hyperlipoproteinemia) A STUDY OF ITS BIOCHEMICAL, GENETIC, AND CLINICAL PRESENTATION IN CHILDHOODJournal of Clinical Investigation, 1974
- NEONATAL DIAGNOSIS OF FAMILIAL TYPE-II HYPERLIPOPROTEINÆMIAThe Lancet, 1973